A comparative analysis of the HUGO<sup>TM</sup> robot‐assisted surgery system and the Da Vinci<sup>®</sup> Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment
Claudia Collà Ruvolo, Margarita Afonina, Eleonora Balestrazzi, Marco Paciotti, Adele Piro, Federico Piramide, Carlo Andrea Bravi, M. Peraire Lores, Gabriele Sorce, Mario Belmonte, Silvia Rebuffo, Marco Ticonosco, Nicola Frego, Giorgia Gaia, Ruben De Groote, Alexandre Mottrie, Geert De Naeyer
Abstract
Abstract Background We aimed to compare the outcomes of Robot‐assisted sacrocolpopexy (RASC) performed using the novel HUGO TM Robot‐Assisted Surgery (RAS) System with the Da Vinci ® Xi surgical system. Methods Data from 38 women undergoing RASC for a ≥ 2‐grade pelvic organ prolapse were collected (2021–2023). Results Overall, 23 (60.5%) and 15 (39.5%) procedures were performed using the DaVinci ® Xi and the HUGO TM RAS system, respectively. The median total operative time was 123 (IQR:106.5–140.5) minutes for the DaVinci ® Xi versus 120 (IQR:120–146) minutes for the HUGO TM RAS cases ( p = 0.5). No conversion to open/laparoscopic surgery, perioperative complications, or system failures occurred. No differences were recorded according to day of catheter removal and length of stay. Conclusions This study represents the first worldwide comparison of RASC executed using the HUGO TM RAS versus the Da Vinci ® Xi System. Our data suggest that RASC might be performed with both robotic platforms with similar perioperative outcomes.